Recent studies have revealed down-regulated sirtuin-1 (SIRT1) in IBD patients and model mice [27] and reduced SIRT1 activity by the down-regulation of NAD+ [34,35]. The gene discussed is SIRT1; the disease is inflammatory bowel disease.